Get started
Author

Elodie Gautier‐Veyret

Observed names: E Gautier-Veyret, E Gautier‐Veyret, E. Gautier-Veyret, E. Gautier-veyret, Elodie Gautier, Elodie Gautier-Veyret, Elodie Veyret-Gautier, Gautier-Veyret, Elodie
Observed institutions: Inserm, Centre Hospitalier Universitaire de Grenoble, Hôpital Européen Georges-Pompidou, Hôpital Albert Michallon, Communauté Université Grenoble Alpes, Hypoxie et Physiopathologies cardiovasculaires et respiratoires, Université Grenoble Alpes
ORCID: 0000-0002-5846-3847
Observed ORCID: 0000-0002-5846-3847
OpenAlex ID: A5085328494
Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment
2020 · Françoise Stanke-Labesque, Elodie Gautier-Veyret, et al. · Pharmacology & Therapeutics · 202
PDF
Variability of Voriconazole Plasma Concentrations after Allogeneic Hematopoietic Stem Cell Transplantation: Impact of Cytochrome P450 Polymorphisms and Comedications on Initial and Subsequent Trough Levels
2015 · Elodie Gautier-Veyret, Xavier Fonrose, et al. · Antimicrobial Agents and Chemotherapy · 67
A multiplex liquid chromatography tandem mass spectrometry method for the quantification of seven therapeutic monoclonal antibodies: Application for adalimumab therapeutic drug monitoring in patients with Crohn's disease
2019 · Théo Willeman, Jean-François Jourdil, et al. · Analytica Chimica Acta · 65
PDF
Intermittent hypoxia-activated cyclooxygenase pathway: role in atherosclerosis
2012 · Elodie Gautier-Veyret, Claire Arnaud, et al. · European Respiratory Journal · 55
PDF
Inflammation is a potential risk factor of voriconazole overdose in hematological patients
2018 · Elodie Gautier-Veyret, A Truffot, et al. · Fundamental and Clinical Pharmacology · 44
PDF
Infliximab quantitation in human plasma by liquid chromatography-tandem mass spectrometry: towards a standardization of the methods?
2016 · Jean-Francois Jourdil, Dorothée Lebert, et al. · Analytical and Bioanalytical Chemistry · 35
Modeling Approach to Predict the Impact of Inflammation on the Pharmacokinetics of CYP2C19 and CYP3A4 Substrates
2021 · Florian Simon, Elodie Gautier-Veyret, et al. · Pharmaceutical Research · 34
Combined Impact of Inflammation and Pharmacogenomic Variants on Voriconazole Trough Concentrations: A Meta-Analysis of Individual Data
2021 · Léa Bolcato, Charles Khouri, et al. · Journal of Clinical Medicine · 33
PDF
Pharmacokinetic herb‐drug interaction between ginger and crizotinib
2019 · Bruno Revol, Elodie Gautier‐Veyret, et al. · British Journal of Clinical Pharmacology · 32
Leukotrienes as a molecular link between obstructive sleep apnoea and atherosclerosis
2013 · Françoise Stanke-Labesque, Jean-Louis Pépin, et al. · Cardiovascular Research · 32
Quantitative impact of pre‐analytical process on plasma uracil when testing for dihydropyrimidine dehydrogenase deficiency
2022 · Maud Maillard, Manon Launay, et al. · British Journal of Clinical Pharmacology · 28
PDF
Pharmacogenetics may Influence the Impact of Inflammation on Voriconazole Trough Concentrations
2017 · Elodie Gautier-Veyret, Sebastien Bailly, et al. · Pharmacogenomics · 28
Optimization of voriconazole therapy for treatment of invasive aspergillosis: Pharmacogenomics and inflammatory status need to be evaluated
2020 · Elodie Gautier‐Veyret, Anne Thiebaut‐Bertrand, et al. · British Journal of Clinical Pharmacology · 27
Simultaneous Quantification of Adalimumab and Infliximab in Human Plasma by Liquid Chromatography–Tandem Mass Spectrometry
2018 · Jean-François Jourdil, Benjamin Némoz, et al. · Therapeutic Drug Monitoring · 27
Simultaneous quantification of rituximab and eculizumab in human plasma by liquid chromatography-tandem mass spectrometry and comparison with rituximab ELISA kits
2020 · Aurélie Truffot, Jean-François Jourdil, et al. · Clinical Biochemistry · 25
PDF
Variability of Isavuconazole Trough Concentrations during Longitudinal Therapeutic Drug Monitoring
2022 · Léa Bolcato, Anne Thiebaut-Bertrand, et al. · Journal of Clinical Medicine · 24
PDF
Treatment by Posaconazole Tablets, Compared to Posaconazole Suspension, Does Not Reduce Variability of Posaconazole Trough Concentrations
2019 · Elodie Gautier-Veyret, Léa Bolcato, et al. · Antimicrobial Agents and Chemotherapy · 24
Impact of Loading Dose of Caspofungin in Pharmacokinetic-Pharmacodynamic Target Attainment for Severe Candidiasis Infections in Patients in Intensive Care Units: the CASPOLOAD Study
2020 · Sébastien Bailly, Elodie Gautier-Veyret, et al. · Antimicrobial Agents and Chemotherapy · 20
Unexpected overdose blood concentration of tacrolimus: Keep in mind the role of inflammation
2020 · Edouard Bonneville, Elodie Gautier‐Veyret, et al. · British Journal of Clinical Pharmacology · 18
Cysteinyl-leukotriene pathway as a new therapeutic target for the treatment of atherosclerosis related to obstructive sleep apnea syndrome
2018 · Elodie Gautier-Veyret, Magnus Bäck, et al. · Pharmacological Research · 17
Pharmacogenetics of Voriconazole: CYP2C19 but Also CYP3A4 Need to Be Genotyped
2017 · E Gautier‐Veyret, X Fonrose, et al. · Clinical Pharmacology & Therapeutics · 16
Artificial increase of uracilemia during fluoropyrimidine treatment can lead to DPD deficiency misinterpretation
2021 · F. Thomas, M. Maillard, et al. · Annals of Oncology · 15
PDF
Refining the therapeutic range of posaconazole and isavuconazole for efficient therapeutic drug monitoring using a bioassay approach
2019 · Théo Willeman, Julia Tonini, et al. · Fundamental and Clinical Pharmacology · 15
Variability of Tacrolimus Trough Concentration in Liver Transplant Patients: Which Role of Inflammation?
2021 · Anaelle Chavant, Xavier Fonrose, et al. · Pharmaceutics · 14
PDF
Tablets or oral suspension for posaconazole in lung transplant recipients? Consequences for trough concentrations of tacrolimus and everolimus
2020 · Sébastien Chanoine, Elodie Gautier‐Veyret, et al. · British Journal of Clinical Pharmacology · 14
Works count: 62
Citation count: 1,042
H-index: 18
I10-index: 28
Year
Topic
Type